Cart
sales@molnova.com
1,4-Dideoxy-1,4-epithio-D-ribitol
CAS No. 190315-43-6
1,4-Dideoxy-1,4-epithio-D-ribitol( —— )
Catalog No. M37903 CAS No. 190315-43-6
1,4-Dideoxy-1,4-epithio-D-ribitol is a purine nucleoside analog that targets malignant tumors of the inert lymphatic system and possesses a broad spectrum of antitumor activity.1,4-Dideoxy-1,4-epithio-D-ribitol induces apoptosis through inhibition of DNA synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 314 | In Stock |
|
| 200MG | 458 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1,4-Dideoxy-1,4-epithio-D-ribitol
-
NoteResearch use only, not for human use.
-
Brief Description1,4-Dideoxy-1,4-epithio-D-ribitol is a purine nucleoside analog that targets malignant tumors of the inert lymphatic system and possesses a broad spectrum of antitumor activity.1,4-Dideoxy-1,4-epithio-D-ribitol induces apoptosis through inhibition of DNA synthesis.
-
Description(2R,3S,4R)-2-(Hydroxymethyl)tetrahydrothiophene-3,4-diol is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis | Apoptosis | Nucleoside Antimetabolite/Analog
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number190315-43-6
-
Formula Weight150.2
-
Molecular FormulaC5H10O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(O)[C@@H]1[C@@H](O)[C@@H](O)CS1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.?
molnova catalog
related products
-
Deoxyshikonin
Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases.
-
Cytarabine
Cytarabine (AraC) is an antimetabolic agent and DNA synthesis inhibitor.
-
Tetrahydrouridine
Tetrahydrouridine (THU) is a multidrug resistance modulator. It can be used in cancer treatment to make tumor cells more sensitive to radiation therapy.
